ѻý

Glucose Supplement Recalled; ADA Sued by Former Employee; Forteo Generic OK'd

<ѻý class="mpt-content-deck">— News and commentary from the endocrinology world
MedpageToday
Endo Break over a computer rendering of a man with illustrated body organs.

The of an over-the-counter glucose support supplement for the presence of metformin and glyburide.

Over the past two decades, the prevalence of from 7.8% to 14.9% and from 33% to 44% among higher-income, middle-age Americans. (Annals of Internal Medicine)

Former director of nutrition for the after she was allegedly fired for objecting to the promotion of sugar substitute Splenda. (Reuters)

Two metabolites may help are more likely to develop prediabetes. (Diabetes Care)

The FDA approved a (Forteo) for certain adults with osteoporosis, said Teva Pharmaceuticals.

Referral to a large-scale, established behavior change program for prediabetes , researchers found. (Nature)

Following a meeting with the FDA in August, Ascendis Pharma palopegteriparatide (TransCon PTH) for approval.

about their periods, researchers suggested comprehensive menstrual education in schools, for girls and boys, along with improved training for healthcare professionals to engender better community support and promote quality of life for women as they navigate perimenopausal symptoms and changes. (Post Reproductive Health)

To (Wegovy, Ozempic) for weight loss, Connecticut's state employee health plan is requiring that members first enter a lifestyle management program. (Politico)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.